Nifty Pharma index rises 2% as Sun Pharma, Lupin receive USFDA approval

Sun Pharma rose over 3 per cent to an intra-day high of Rs 670.90 on the NSE after the drug maker announced USFDA approval of XELPROS to treat open-angle Glaucoma or Ocular Hypertension.

from Latest News https://ift.tt/2MwjmsS

Facebook Google Twitter More

• Pinterest
• Linkedin
• Tumblr

Posted by : Camera Guru 12:31 pm Tags : Latest News

Subscribe by Email

Follow Updates Articles from This Blog via Email